COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $972 | -50.1% | 260 | -8.8% | 0.00% | – |
| Q1 2023 | $1,949 | -80.8% | 285 | -77.8% | 0.00% | – |
| Q4 2022 | $10,177 | -21.7% | 1,285 | -3.2% | 0.00% | – |
| Q3 2022 | $13,000 | +44.4% | 1,328 | +3.3% | 0.00% | – |
| Q2 2022 | $9,000 | -79.5% | 1,285 | -61.8% | 0.00% | – |
| Q1 2022 | $44,000 | -27.9% | 3,368 | -12.3% | 0.00% | – |
| Q4 2021 | $61,000 | +10.9% | 3,841 | +11.6% | 0.00% | – |
| Q3 2021 | $55,000 | -26.7% | 3,441 | -36.3% | 0.00% | – |
| Q2 2021 | $75,000 | +82.9% | 5,406 | +90.4% | 0.00% | – |
| Q1 2021 | $41,000 | -16.3% | 2,840 | 0.0% | 0.00% | – |
| Q4 2020 | $49,000 | -5.8% | 2,840 | 0.0% | 0.00% | – |
| Q3 2020 | $52,000 | +10.6% | 2,840 | +8.2% | 0.00% | – |
| Q2 2020 | $47,000 | – | 2,625 | +26150.0% | 0.00% | – |
| Q3 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |